Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
MSHSB had on 8 October 2020 entered into a tenancy agreement with Minho Kilning (Klang)
Sdn Bhd (the “Landlord”) to occupy part of a land measuring approximately 313,548 square
那么简单,我都看明白何况MS企业那么多经验的精英
申请着美国和欧美的标准许可证 FDA 如下
During the COVID-19 public health emergency, the FDA does not expect manufacturers to submit notification to FDA before they begin marketing their product or to comply with certain regulatory requirements where the medical gloves do not create an undue risk in light of the pandemic as outlined in the FDA’s policy for gloves that is in effect during the COVID-19 public health emergency.
Under the policy, the FDA believes patient examination gloves do not create such an undue risk where:
The gloves include labeling that:
Accurately describes the product as an “unpowdered glove” (as opposed to a “surgeon’s glove”);
Accurately describes of the product’s sterility status (i.e., non-sterile);
Does not claim that the product is latex-free or otherwise free of a specific material;
Includes a list of the body contacting materials; and
Includes recommendations and general statements that would reduce the risk of use. For example:
A statement that the gloves have not been cleared by FDA.
A recommendation against using when FDA-cleared gloves are available.
A recommendation against using in surgical settings.
The product is not intended for any use that would create an undue risk. For example, the labeling does not include uses with chemotherapy drugs, fentanyl, and other opioids, for allergy or dermatitis prevention, for antimicrobial or antiviral protection, or for infection prevention or reduction.
Under the policy, the FDA believes that surgeon’s gloves do not create such an undue risk where:
The gloves meet the standard described in ASTM D3577External Link Disclaimer and have been manufactured in compliance with good manufacturing practices.
The gloves include labeling that:
Accurately describes product as being unpowdered;
Accurately describes the product’s sterility status (i.e., sterile) and the sterilization method used;
Does not claim that the product is latex-free or otherwise free of a specific material;
Includes a list of the body contacting materials; and
Includes recommendations and general statements that would reduce the risk of use. For example:
A statement that the gloves have not been cleared by FDA.
A recommendation against use when FDA-cleared surgeon’s gloves are available.
The product is not intended for any use that would create an undue risk. For example, the labeling does not include uses with chemotherapy drugs, fentanyl, and other opioids, for allergy or dermatitis prevention, for antimicrobial or antiviral protection, or for infection prevention or reduction.